NEU neuren pharmaceuticals limited

Growth potential is part of fundamental analysis, as is...

  1. 150 Posts.
    lightbulb Created with Sketch. 107
    Growth potential is part of fundamental analysis, as is debt-to-equity, good management, competitive advantage, and a consistent revenue stream.
    NEU by any standard has strong fundamentals.

    Also, please answer Marcor's question regarding this piece of bs: "My understanding is that there is a chance endpoints may not be agreed upon until mid year"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.